NeuroMetrix Files 2024 10-K, Details Financials
| Field | Detail |
|---|---|
| Company | Neurometrix, Inc. |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, financials, medical-devices
Related Tickers: NURO
TL;DR
NURO 2024 10-K filed. Full financials out for FY24. Check it.
AI Summary
NeuroMetrix, Inc. filed its 2024 10-K on March 31, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The filing details the company's financial position, including common stock, preferred stock, and additional paid-in capital. Key financial data from December 31, 2022, 2023, and 2024 are presented.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of NeuroMetrix, Inc.'s financial health and performance for the fiscal year 2024, enabling informed investment decisions.
Risk Assessment
Risk Level: medium — The company's financial performance and future prospects are subject to the inherent risks of the medical device industry and its specific market position.
Key Numbers
- 12/31/2024 — Fiscal Year End (Reporting period for the 10-K)
- 12/31/2023 — Previous Fiscal Year End (Comparative financial data)
- 12/31/2022 — Prior Fiscal Year End (Further comparative financial data)
Key Players & Entities
- NeuroMetrix, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-31 (date) — Filing date
- Waltham, MA (location) — Company headquarters
FAQ
What is the primary business of NeuroMetrix, Inc.?
NeuroMetrix, Inc. is in the Surgical & Medical Instruments & Apparatus industry, SIC code 3841.
When was the 10-K filing submitted?
The 10-K filing was submitted on March 31, 2025.
What fiscal year does this 10-K report cover?
This 10-K report covers the fiscal year ending December 31, 2024.
Where is NeuroMetrix, Inc. headquartered?
NeuroMetrix, Inc. is headquartered at 1000 Winter Street, Waltham, MA 02451.
What types of stock are mentioned in the filing data?
The filing data mentions Common Stock, Preferred Stock, Convertible Preferred Stock (Series B), and Preferred Stock Purchase Rights.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding NeuroMetrix, Inc..